Clinical Study
Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
Table 2
Comparison of clinical data after 12-month treatment of intravitreal aflibercept or bevacizumab for macular edema secondary to branch retinal occlusion.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
BCVA: best-corrected visual acuity. CFT: central foveal thickness. |